Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
International Journal of Cancer|May 8, 1993
Anomalous expression of P-glycoprotein in highly drug-resistant human KB cellsE D Dolci, R Abramson, Y Xuan, et al.Biochemistry|June 27, 1989
DNA cross-linking by intermediates in the mitomycin activation cascadeC Cera, M Egbertson, S P Teng, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 1999
Interaction of calicheamicin gamma1(I) and its related carbohydrates with DNA-protein complexesC Sissi, J Aiyar, S Boyer, et al.Journal of Biomolecular NMR|January 1, 1995
Sequential correlation of anomeric ribose protons and intervening phosphorus in RNA oligonucleotides by a 1H, 13C, 31P triple resonance experiment: HCP-CCH-TOCSYJ P Marino, H Schwalbe, C Anklin, et al.Biochemistry|February 1, 1994
Binding affinity and site selectivity of daunomycin analoguesC J Roche, D Berkowitz, G A Sulikowski, et al.Journal of Chromatography|May 25, 1990
Rapid high-performance liquid chromatography of nucleic acids with polystyrene-based micropellicular anion exchangersY F Maa, S C Lin, C Horváth, et al.Advances in Experimental Medicine and Biology|January 1, 1989
Kinin receptors on epithelial cells and smooth muscle of the tracheaK D Bhoola, J Bewley, D M Crothers, et al.The American Journal of Physiology|October 12, 1999
Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosisC L Zanella, C R Timblin, A Cummins, et al.Science (New York, N.Y.)|September 14, 1990
Fragments of the HIV-1 Tat protein specifically bind TAR RNAK M Weeks, C Ampe, S C Schultz, et al.Anti-Cancer Drug Design|February 1, 1990
New insight into drug-DNA interactions at individual drug binding sites probed by RNA polymerase during active transcription of the DNAD R Phillips, R J White, H Trist, et al.Pageof 21